Events & Webinars

Throughout the year, Reorg hosts and participates in events, conferences, and webinars bringing together industry professionals to discuss themes in the performing, distressed, restructuring and post-reorg credit markets.

Events & Webinars

 

 

Upcoming Events & Webinars
Jan 31- Feb 3
 2023 TMA Distressed Investing Conference

Meet Reorg’s team at this year’s TMA conference for corporate restructuring and distressed investing professionals.

 Las Vegas Register Now
Feb 1
4-6 p.m. ET		 Seminar: After the Dust Settles: Article 7 Reporting for 2023 and Beyond

Join Dechert’s John McGrath, Rory O’Connor and Glenn Weston, as well as guest speakers Tejs Broberg of FinDox Inc. by Reorg and Michael Moffitt of TMF Group, for a discussion on the changing regulatory landscape in the securitization and CLO market.

 New York Register Now
Feb 8
2 p.m. GMT
9 a.m. ET		 Reorg Webinar: European Leveraged Finance Trends – How Covenants Evolved in 2022

Join Reorg’s senior legal analysts Brian Conway, Ian Chin and Bart Capeci on Wednesday, Feb. 8 as we discuss the latest trends in leveraged loan and high-yield bond covenants.

 London Register Now
Feb 9 Portfolio Adviser Emerging Markets Conference 

Portfolio Adviser Emerging Markets is an investment forum aimed at senior investment professionals involved in the fund selection process including investment managers, portfolio managers, researchers and analysts.

 London Register Now
Feb 24,
8 a.m. ET		 Wharton Restructuring & Distressed Investing Conference 2023

Join Reorg at the 19th Annual Wharton Restructuring and Distressed Investing Conference, which will cover the current economic climate and issues of debt, investing and restructuring across the globe.

 New York Register Now
Mar 6-7
 SuperReturn Private Credit Europe Conference 

Join 300+ senior LPs and GPs to explore the latest investment opportunities and market trends.

 London Register Now

 

See below for recent webinars, and click through to access the replays.

 

 

What our webinar attendees say…

 

“As a non-lawyer representative of bank debt claims in Chapter 11 bankruptcies, I very much enjoyed and learned from Kevin Eckhardt’s plain-speaking explanation of this new Texas 2-step strategy.”
– Mizuho Bank

 

“The balance between detail and high level was excellent. ”
– Micro Insurance Company Ltd

 

“Excellent overview with pertinent recent examples. In particular, a good overview of offshore vs. onshore considerations.”
– KRZ Ltd

The Perfect Storm? Facing the Year Ahead in Asian Credit and Restructuring

January 11, 2023

What lies ahead in 2023 in Asian restructuring and where are the opportunities for investors? Asia’s high-yield market in 2022 was hit by multiple defaults in China’s real estate sector. “Three Red Lines”, frozen escrow accounts, follow-on LMEs, and opaque onshore restructuring processes, all contributed to substantial losses in Asian high-yield markets.

Access the replay now >>

China’s Regulatory Stimulus, Impact on Real Estate Sector, Asia High Yield Market

December 13, 2022

Will the new policies end China’s real estate crisis? How much will they help lift the industry out of its recession? Could this be the turning point people were hoping for? And how long will the exuberance last? In this webinar, Reorg’s China editorial team shared their take on the situation.

Access the replay now >>

Primary in the Eye of the Storm: Challenges and Opportunities in Leveraged Finance in a Downturn

December 1, 2022

Reorg hosted a panel discussion on the outlook for the primary and secondary leveraged finance markets. During the webinar, we provided an overview of new trends in deal structures, private credit as an alternative tool in the syndicated loan market, developments in covenants, where future opportunities lie and the outlook for 2023 after muted issuance in 2022.

Access the replay now >>

Winter of Discontent: Distressed Debt and Restructuring Outlook for Germany

November 17, 2022

With German corporates facing a winter of high gas prices, subdued consumer confidence and rising interest rates, the panel discussed what opportunities and challenges investors and restructuring professionals can expect.

Access the replay now >>

Hot Topics In Crypto Winter: Developments in Celsius, Voyager and Beyond

November 2, 2022

Our expert panel discussed the novel issues raised in recent cryptocurrency bankruptcy filings, provided an overview of the state of the crypto industry, reviewed the trajectory of the ongoing reorganizations of cryptocurrency exchanges Voyager Digital and Celsius Network, and more.

Access the replay now >>

Orpea Starts Second Round of Conciliation is Less Than a Year

October 31, 2022

In this webinar our panel discussed the chain of events which led the French care home operator to start a second round of debt talks in less than a year; Orpea’s current and expected financial position after management’s announcement that EBITDAR decline may lead to a breach in financial covenants, and the French legal restructuring framework, with a focus on the Conciliation process and new Accelerated Safeguard Process.

Access the replay now >>

GenesisCare: Ill-Fated US Acquisition Leaves Group Heading for Restructuring

October 5, 2022

Reorg hosted another episode of our deep dive webinar series, this time on Australia-headquartered radiology services group GenesisCare, which bought U.S.-based 21st Century Oncology out of bankruptcy in 2019 in a transformative deal.

Access the replay now >>

Winter Came for Covid-Era Darlings? – Distress in Crypto and Tech

August 25, 2022

Crypto and tech companies have attracted substantial capital and interest during the pandemic. But the music is slowing down, as central banks on both sides of the Atlantic take liquidity out of the financial markets. How did we get here, what is the status quo, and what’s next?

Access the replay now >>

Bausch’s Remedies for Potential Patent Defeat & Creditor Angst Over B+L Spin

August 16, 2022

In this webinar Reorg’s team discussed the latest events surrounding Bausch Health. We walked through a variety of topics, including the Bausch + Lomb spinoff, Xifaxan (patent trial and competition), the company’s options in light of covenant limitations, and more.

Access the replay now >>
Thank you for signing up
for Reorg on the Record!